Trial Profile
A Randomized, Controlled Evaluation of the Safety and Efficacy of a Topical Treatment for Moderate-Severe Facial Acne Vulgaris.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Oct 2012
Price :
$35
*
At a glance
- Drugs BLI 1100 (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- 26 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 23 Nov 2010 New trial record